Procter & Gamble vs PepsiCo: The Better Stock For Passive Income Investors

Photo of Vandita Jadeja
By Vandita Jadeja Published

Quick Read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Procter & Gamble vs PepsiCo: The Better Stock For Passive Income Investors

© BMPhotolab / Shutterstock.com

PepsiCo (NASDAQ: PEP | PEP Price Prediction) and Procter & Gamble (NYSE: PG) both just handed investors fresh earnings, and the businesses behind the tickers are steering in noticeably different directions.

Pepsi posted Q2 2026 results on July 8 with international momentum leading the way. P&G’s fiscal Q3 earnings report landed in late April, driven by Beauty. Both beat, both reaffirmed guidance, and both are wrestling with tariffs.

Snacks Wobble at Pepsi. Beauty Powers P&G.

Pepsi delivered core EPS of $2.20 on $24.18 billion in revenue, up 6.4% year over year. The tell was geography. Latin America Foods jumped 15%, EMEA rose 10%, and Asia Pacific Foods climbed 12%, while PepsiCo Foods North America slipped 2% on lower effective net pricing.

That is a real business problem for Frito-Lay economics at home, even as CEO Ramon Laguarta pointed to “the highest rate [of global organic volume growth] since 2022”.

PEP earnings quotes

P&G’s story was different in texture. Net sales of $21.24 billion grew 7.4%, with Beauty up 7% organically on Hair Care, Skin Care, and Olay premiumization. Every one of the five segments grew. Core EPS came in at $1.59, beating the $1.5552 consensus. New CEO Shailesh Jejurikar framed it plainly: “broad-based growth across product categories and regions.”

Business Driver PepsiCo P&G
Main Growth Engine International beverages and foods Beauty and premium innovation
Soft Spot PFNA (-2%) Fabric & Home Care organic (+3%)
Margin Move Core margin -40 bps Core gross margin -100 bps

Functional Beverages vs. Premium Skin Care

Laguarta wants Pepsi’s portfolio pulled toward “functional benefits such as hydration, protein and fiber, energy and zero sugar beverage varieties“, alongside affordability initiatives to shore up domestic snacks.

PEP price scenario

Jejurikar is doing something bolder on the cost side. P&G announced a plan to cut up to 7,000 non-manufacturing roles by end of FY2027 while pushing innovation-based pricing in Oral Care and Skin Care.

Both companies get hit by tariffs. P&G quantified the pain at roughly $400 million after-tax and now expects results toward the lower end of its FY26 EPS range of $6.83 to $7.09. Pepsi, by contrast, reaffirmed core constant currency EPS growth of 4% to 6% and $8.9 billion in total shareholder returns.

An infographic titled 'PEP vs PG: THE EARNINGS SHOWDOWN' with a dark background and white text, divided into five sections. Section 1, 'RECENT EARNINGS SNAPSHOT,' compares PepsiCo (PEP) and Procter & Gamble (PG). For PepsiCo Q2 2026, Core EPS is $2.20, Revenue $24.18B, and +6.4% YoY growth. For Procter & Gamble Fiscal Q3 2026, Core EPS is $1.59, Net Sales $21.24B, and +7.4% YoY growth. Section 2, 'GROWTH ENGINES & WEAKNESSES,' lists PEP's International Momentum Lead (Latin America Foods +15%, EMEA +10%, Asia Pacific Foods +12%) and weakness in PFNA (-2% Revenue). For PG, 'BROAD-BASED & BEAUTY DRIVEN' growth includes Beauty (Organic) +7%, Grooming & Health Care +7% each, and Fabric & Home Care +7%, with a Core Gross Margin decrease of -100 bps. Section 3, 'STRATEGY DIVERGENCE,' features headshots of Ramon Laguarta for PEP, focusing on 'FUNCTIONAL & AFFORDABLE,' and Shailesh Jejurikar for PG, focusing on 'PREMIUM INNOVATION & RESTRUCTURING,' with associated quotes and icons. Section 4, 'THE DIVIDEND ARISTOCRATS,' states PEP has a 54th Consecutive Increase and PG a 70th Consecutive Increase. Section 5, 'INVESTOR TAKEAWAY,' presents 'THE FINAL READ' recommending 'LEAN PG FOR QUALITY' and 'LEAN PEP FOR REBOUND.' Data is as of Friday, July 10, 2026.
24/7 Wall St.

The Next Test Is Domestic Snack Pricing and Tariff Absorption

I want to see whether Pepsi can stop the pricing bleed in Frito-Lay without gutting margin, and whether poppi, Gatorade, and the zero sugar push can keep offsetting soft PFNA.

For P&G, the tell will be Beauty holding a 7% organic pace while restructuring hits and tariff costs stay sticky. The 70th consecutive dividend increase and Pepsi’s 54th look secure; the unit economics behind them are the open question.

Why I Lean P&G for Quality, Pepsi for the Rebound Trade

If I want the cleaner operating story right now, I lean toward P&G. Every segment grew, Beauty is doing real premium work, and Jejurikar’s cost plan gives me a lever if tariffs stay elevated. The stock reflects it: PG is up 3.95% year to date, while PEP sits down 2.08%.

If I want more upside variance, Pepsi is the more interesting file. A forward P/E of 17 and 3.92% dividend yield pay me to wait while PFNA stabilizes. I would not chase either aggressively until I see two more quarters of margin direction. That is the read.

Contact [email protected] for any questions or corrections.

Photo of Vandita Jadeja
About the Author Vandita Jadeja →

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561